ResearcherUniversity of BernNo recent work listed

Maria Saliakoura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9021-2151; OpenAlex author ID A5079590394. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy. Co-author DOI 10.1186/s13046-021-02231-y ↗
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression. Co-author DOI 10.1126/sciadv.abb9200 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Matteo Rossi Sebastiano · 2 shared papers, 2020–2022 · strength 0.31
- Paper Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy. DOI 10.1186/s13046-021-02231-y ↗
- Paper ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression. DOI 10.1126/sciadv.abb9200 ↗
Georgia Konstantinidou · 2 shared papers, 2020–2022 · strength 0.31
- Paper Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy. DOI 10.1186/s13046-021-02231-y ↗
- Paper ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression. DOI 10.1126/sciadv.abb9200 ↗
Eva Karamitopoulou · 1 shared paper, 2020 · strength 0.11
- Paper ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression. DOI 10.1126/sciadv.abb9200 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.